Clinical trial · Interventional
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
NCT06843720CI-TRIAL-00115632recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HR-HPV Testing | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| HR-HPV Testing | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Participants participate in an interview or a focus group discussion and provide opinions about self-collection and/or education and training materials for participants and providers. Partipants participation in this study may be limited to a single interview or focus group discussion. Some stakeholders will be asked to participate in additional interviews and/or focus groups.
- interventionNames
- Behavioral: HR-HPV Testing
Primary outcomes (1)
- measure
- Safety and Adverse Events (AEs). Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 4.03
- timeFrame
- Through study completion; an average of 1 year.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: Populations involved in the research are: 1. stakeholder advisory board members; 2. patients eligible for cervical cancer screening participating in the cluster randomized stepped-wedge trial; 3. patients and community members participating in formative research activities; 4. providers, clinic staff, and other health system stakeholders from partnering health systems; 5. Project ECHO Participants (providers, clinic staff, and other health system stakeholders from partner and non-partner institutions); 6. Other Clinical Networks (providers, clinic staff and other health system stakeholders from partner and non-partner institutions) The eligibility criteria for each are: Patients eligible for cervical cancer screening: * Currently a resident in the state of Texas * Attend for care at a partner clinic enrolled in the study * Women and persons with a cervix * Age 25-65 * Due or past due for cervical cancer screening Patients and community members participating in formative research activities: • Purposively identified as a stakeholder for formative research by research staff Providers, clinic staff, and other health system stakeholders from partnering health systems: * Employed at least part-time by a partnering health system * Age 18+ Project ECHO Participants: * Participate in at least one Project ECHO session * Age 18+ Other Clinical Networks: * Participate in at least one clinical network session * Age 18+ Exclusion Criteria: Patients eligible for cervical cancer screening: * Report being currently pregnant * History of total hysterectomy * History of cervical cancer Other study populations: • Unable to communicate in English or Spanish Vulnerable Populations Participants/samples belonging to vulnerable populations (children, pregnant women, cognitively impaired adults, or prisoners) will be prohibited from participation.
References
Publications (0)
Data not yet available
No reference posted for this study.